A detailed history of Farther Finance Advisors, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 15 shares of EOLS stock, worth $163. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 50 70.0%
Holding current value
$163
Previous $554,000 56.14%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$10.66 - $17.48 $373 - $611
-35 Reduced 70.0%
15 $243,000
Q2 2024

Jul 31, 2024

BUY
$10.45 - $13.76 $365 - $481
35 Added 233.33%
50 $554,000
Q1 2024

May 13, 2024

SELL
$9.99 - $14.91 $9 - $14
-1 Reduced 6.25%
15 $206,000
Q4 2023

Feb 14, 2024

BUY
$7.6 - $10.53 $121 - $168
16 New
16 $168,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $611M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.